Volume 16, Number 11—November 2010
Research
Outbreaks of Pandemic (H1N1) 2009 and Seasonal Influenza A (H3N2) on Cruise Ship
Table 1
Demographic | No. (%) passengers, n = 1,970 | Confirmed pandemic (H1N1) 2009, n = 78 |
Confirmed influenza A (H3N2), n = 100 |
|||||
---|---|---|---|---|---|---|---|---|
No. (%) | RR (95% CI) | p value | No. (%) | RR (95% CI) | p value | |||
Age group, y | ||||||||
<3 | 13 (1) | 0 | 0 | 1.00 | 1 (1) | 1.52 (0.23–10.16) | 0.67 | |
3–6 | 48 (2) | 20 (26) | 17.43 (10.45–29.09) | <0.001 | 4 (4) | 1.64 (0.62–4.36) | 0.32 | |
7–12 | 119 (6) | 13 (17) | 4.57 (2.40–8.69) | <0.001 | 6 (6) | 1.00 (0.44–2.27) | 0.99 | |
13–18 | 114 (6) | 2 (3) | 0.73 (0.18–3.06) | 1.00 | 5 (5) | 0.87 (0.35–2.12) | 0.75 | |
19–35 | 369 (19) | 18 (23) | 2.04 (1.13–3.70) | 0.020 | 19 (19) | 1.02 (0.61–1.69) | 0.95 | |
36–65 | 1,046 (53) | 25 (32) | Referent | – | 53 (53) | Referent | – | |
>65 |
261 (13) |
0 |
0.00 (undefined) |
0.005 |
12 (12) |
0.91 (0.50–1.70) |
0.76 |
|
Sex | ||||||||
M | 842 (43) | 35 (45) | Referent | 47 (47) | Referent | |||
F |
1,128 (57) |
43 (55) |
0.92 (0.59–1.42) |
0.70 |
53 (53) |
1.19 (0.60–1.2) |
0.38 |
|
Residence | ||||||||
NSW | 1,135 (58) | 47 (60) | Referent | – | 62 (62) | Referent | – | |
Victoria | 433 (22) | 11 (14) | 1.12† (0.72–1.74) | 0.63 | 16 (16) | 0.83† (0.56–1.24) | 0.36 | |
QLD | 165 (8) | 10 (13) | 12 (12) | |||||
SA | 109 (6) | 4 (5) | 4 (4) | |||||
WA | 54 (3) | 0 | 4 (4) | |||||
ACT | 39 (2) | 3 (4) | 1 (1) | |||||
Tasmania | 12 (1) | 1 (1) | 0 | |||||
NT | 2 (0) | 0 | 0 | |||||
Not Australia | 7 (0) | 2 (3) | 1 (1) | |||||
Unknown | 14 (1) | 0 | 0 |
*Diagnosis received during 7-day period after the cruise. RR, relative risk; CI, confidence interval; –, not applicable; NSW, New South Wales; QLD, Queensland; SA, South Australia; WA, Western Australia; ACT, Australian Capital Territory; NT, Northern Territory.
†Relative risks compared NSW residents with non–NSW residents. Two co-infected case-patients have been counted in both influenza categories. The 2 case-patients with positive results from point-of-care testing on board but no further subtyping results are excluded from this table.
Page created: March 04, 2011
Page updated: March 04, 2011
Page reviewed: March 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.